Citeline

Prepare, approve, and submit clinical trial disclosure requirements to multiple registries with only one form. Trialscope Disclose Core Data eliminates duplication and saves time: https://ow.ly/FKAH50Tz8ER.

Citeline Connect seamlessly blends technology and services to expand recruitment channels and accelerate study enrollment: https://ow.ly/TARo50SW9Gm. This integrated, modular solution can be tailored to specific needs so you can effortlessly meet your enrollment targets.

Don’t miss our latest report with the ISCT, International Society for Cell & Gene Therapy! https://ow.ly/9Vsq50UmyAe This Global Regulatory Report provides an overview of the cell and gene therapy regulatory landscape, including pipeline, late-stage (Phase III and pre-registration), approved products, covering cell, genetically modified cell and gene therapies. Read it for free now. ________ Follow Citeline the leading provider of drug, device, company, clinical trial and market intelligence in the pharmaceutical and medtech markets.

Have you tried the all-new Citeline News and Insights app? Access all your favorite award-winning publications, all in one place. Download the app today: https://ow.ly/yuPw50SAjV7. (Available on the App Store and Google Play.)

Breaking News! 📰 Major announcements and exclusive interviews coming your way from #JPM2025. Sign up for daily updates! https://ow.ly/PoE250UmriT. _____ Follow Citeline, the leading provider of drug, device, company, clinical trial and market intelligence in the pharmaceutical and medtech markets.

Last year was a hot pharma year for new active substances (NASs), but there are a few rain clouds forecasted. Our reports, infographics, audiobook and webinar are here to help determine where the outlook is sunny and where clouds are forming: https://ow.ly/zQyp50T2a7N.

Breaking News! 📰 Major announcements and exclusive interviews coming your way from #JPM2025. Sign up for daily updates! https://ow.ly/mAea50Umouz. _____ Follow Citeline Commercial for your comprehensive industry news and strategic insights into the global life sciences and biotechnology markets.

🎥 Japanese webinar, The Key to Winning in Complex Disease Markets: https://ow.ly/JTUy50UlGJ1. The Role of Real-World Data in Unraveling the Patient Journey Join us for an insightful session packed with actionable strategies in just 30 minutes! ・ Date: Tuesday, December 10, 2:00 PM – 2:30 PM JST ・ Format: Zoom ・ Language: Japanese) ・ Fee: Free (Pre-registration required) ・ Language:Japanese Don’t miss out—register now! ⬇️ https://ow.ly/JTUy50UlGJ1 Discover how real-world data can empower your success in complex disease markets.

Congratulations to Kate Bowie, senior reporter at Chemist+Druggist! https://ow.ly/2sv850UkMAw. Kate won Content of the Year in the PPA Independent Publisher Awards for a series of exclusive articles on the weight-loss drug Wegovy. Judges said they were “impressed with a marvelous piece of journalism that had wide, important, and far-reaching impact." ____ Click and follow Citeline the leading provider of drug, device, company, clinical trial and market intelligence in the pharmaceutical and medtech markets.

Did you know that between 2019 and 2023, 31% of the world's clinical trials were conducted in China? https://ow.ly/Uti150Ukfbv In this must-read article, Janelle Hart (Managing Editor), Xu Hu, PhD (Senior Reporter, APAC), and Jie (Dexter) Yan (Senior Editor, APAC) from Citeline, a Norstella company, share valuable insights into the trends fueling China's growth in clinical trials. They explore how China has emerged as a leader in drug development and discuss the challenges it faces moving forward. Click the link in this post for access to the full article. #ClinicalTrials #PharmaInnovation #ChinaBiotech #DrugDevelopment #LifeSciences